Viruses · 2022 · 31 citations · 42 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdjuvant DevelopmentVaccinationVaccine DevelopmentVaccine EfficacyVaccine FormulationViral VaccinesAdjuvant Design For VaccinesAdjuvant Effects On EfficacyAdjuvants For Subunit VaccinesCoronavirus VaccinesVaccinal AdjuvantsVaccination AdjuvantsVaccine Adjuvant DevelopmentVaccine Adjuvant Therapy
Several countries have made unremitting efforts to develop an optimal vaccine in the fight against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing occurrence of SARS-CoV-2 variants, current vaccines show decreased neutralizing activities, especially towards the Omicron variant. In this context, adding appropriate adjuvants to COVID-19 vaccines can substantially reduce the number of required doses and improve efficacy or cross-neutralizing protection. We mainly focus on research progress and achievements associated with adjuvanted COVID-19 subunit and inactivated vaccines. We further compare the advantages and disadvantages of different adjuvant formulations in order to provide a scientific reference for designing an effective strategy for future vaccine development.
42
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu, Dingyu Zhang, Xingwang Li et al. · New England Journal of Medicine · 2020 · 30.4K citations · Full text
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text